Helen Torley
Vermogen: 51 M $ op 31-05-2026
Vermogen: 51 M $ op 31-05-2026
Helen I. Torley bekleedt de functie van President, Chief Executive Officer & Director bij Halozyme Therapeutics, Inc. Zij is ook lid van de raad van bestuur van Quest Diagnostics, Inc. en Director & Member-Health Section Governing Board bij Biotechnology Innovation Organization en lid van The Royal College of Physicians. In het verleden was zij Vice President & GM-United States Bone Health bij Amgen, Inc. en Chief Commercial Officer & Executive VP voor Onyx Pharmaceuticals, Inc. (een dochteronderneming van Amgen, Inc.), Vice President-Medical Affairs van Novartis, Inc., Vice President-Medical Affairs voor Sandoz SA en Vice President-Cardiovascular & Metabolic Sales bij Bristol-Myers Squibb World Wide Medicines Group. Zij heeft een bachelorgraad behaald aan de Universiteit van Glasgow.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-06-2026 | 767.780 ( 0,65% ) | 51 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Algemeen Directeur | 06-01-2014 |
| ANTARES PHARMA, INC. | Directeur/Bestuurslid | 24-05-2022 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Directeur/Bestuurslid | 18-05-2022 |
| RELYPSA INC | Directeur/Bestuurslid | 01-09-2016 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Operationeel Directeur | 15-12-2011 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2002 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Quest Diagnostics, Inc.
Quest Diagnostics, Inc. Services to the Health IndustryHealth Services Provides diagnostic testing and information services | Health Services |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Sandoz SA |
Kies jouw editie
Alle financiële informatie op nationaal niveau